RxDoctor Payments Data

Robert Daniels, MD

Otology & Neurotology · Grand Rapids, MINPI 1386635969

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,405 of the $3,294 with a category attached, or 73.0%. 14 manufacturers reported payments, led by Cochlear Americas at 47.3% of the total. Reporting peaked in 2019 at $1,388 and has fallen 87.3% since, to $177 in 2025.

$3,294in general payments, 2019–2025

Across 52 payments — averaging $63.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$2K
  • Advanced Bionics, LLC$1K
  • Med-el Corporation$246
  • Regeneron Healthcare Solutions, Inc.$147
  • Acclarent, Inc$103
  • Stryker$64
  • plus $164 from 8 others

What the payments were for

  • Travel & lodging$88927%
  • Food & beverage$2,40573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,294 in reported general payments places this provider in the 65th percentile of 23 otology & neurotology providers in Michigan.

See all otology & neurotology providers in Michigan

Medicare billing

Part B allowed, 2024
$53,603
Medicare patients
143
Services billed
341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ajovy AutoinjectorFremanezumab-Vfrm22$16,434
Spironolactone-HctzSpironolact/Hydrochlorothiazid126$7,347
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth36$4,383
Montelukast Sodium227$4,227
Verapamil ErVerapamil Hcl61$1,850
Venlafaxine Hcl ErVenlafaxine Hcl73$1,301
Nortriptyline Hcl77$1,069
Topiramate61$607
Methylprednisolone91$523
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid30$517
Ciprofloxacin Hcl48$487
Cephalexin93$439
Duloxetine Hcl11$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen65$155
Fluticasone Propionate14$124

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →